Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma

• Päätekijät: Chen R (Tekijä), Chen B (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Dove Medical Press, 2015-03-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Runzhe Chen, Baoan Chen Department of Hematology and Oncology (Key Department of Jiangsu Medicine), Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People’s Republic of China Abstract: Brentuximab vedotin is a promising antibody–drug conjugate (...